Steroid receptors in human breast tumorigenesis and breast cancer progression (Q34631186)

3 August 2017

1 reference

title

Steroid receptors in human breast tumorigenesis and breast cancer progression (English)

1 reference

3 August 2017

1 reference

1

1 reference

3 August 2017

Watson P

2

1 reference

3 August 2017

publication date

1 March 2002

1 reference

Biomedicine and Pharmacotherapy

3 August 2017

published in

1 reference

3 August 2017

volume

56

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

65-77

1 reference

Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Histological and biological evolution of human premalignant breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogen responsiveness and control of normal human breast proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Progesterone receptor A and B isoforms in the human breast and its disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Role of the androgen receptor in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Mammary gland development and tumorigenesis in estrogen receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: basis for a new classification

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Progestin regulation of cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogen receptors alpha and beta form heterodimers on DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

The multifaceted mechanisms of estradiol and estrogen receptor signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogens and progestins in mammary development and neoplasia. Introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Use of PRKO mice to study the role of progesterone in mammary gland development

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Rapid actions of plasma membrane estrogen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Ovarian hormone receptors in human mammary stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Hypoxia reduces hormone responsiveness of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Lumican and decorin are differentially expressed in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogen receptor variants in normal human mammary tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Oestrogen-responsive human breast cancer in long term tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts: immunocytochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Nuclear receptor coregulators: cellular and molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Functions of 1alpha,25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Oestrogen receptor: a stable phenotype in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Dynamic reciprocity revisited: a continuous, bidirectional flow of information between cells and the extracellular matrix regulates mammary epithelial cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogen receptors alpha and beta in the rodent mammary gland

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogen receptor-positive proliferating cells in the normal and precancerous breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Oestrogen receptor expression in the normal and pre-cancerous breast

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Molecular mechanisms of action of steroid/thyroid receptor superfamily members

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Expression of alpha-thymosins in human tissues in normal and abnormal growth

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Oestrogen receptor and its potential role in breast cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900157-3

7 January 2021

10.1016/S0753-3322(01)00157-3

Identifiers

DOI

1 reference

3 August 2017

1 reference